Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
NCT07220915
- Conditions
- Agammaglobulinemia, Autoimmune Conditions, Blood Protein Disorders, +9 more
- Locations
-
- Perseverance Research Center, Phoenix Neurological Associates Scottsdale, Arizona, United States
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
NCT05357781
- Conditions
- Agammaglobulinemia, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
- Locations
-
- University Hospital of Bern Inselspital Bern, Canton of Bern, Switzerland
- Conditions
- Agammaglobulinemia, B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, +25 more
- Locations
-
- GC2202 Study Site 115 Huntington Park, California, United States
- GC2202 Study Site 103 St. Petersburg, Florida, United States
- GC2202 Study Site 111 Bethesda, Maryland, United States
- GC2202 Study Site 109 Greenville, North Carolina, United States
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
NCT06976476
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activity) Commack, New York, United States
NCT05678621
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Haematological Malignancy, +16 more
- Locations
-
- Canberra Hospital Garran, Australian Capital Territory, Australia
- Concord Hospital Concord, New South Wales, Australia
- Royal North Shore St Leonards, New South Wales, Australia
- Monash Medical Centre Clayton, Victoria, Australia
NCT02231879
- Conditions
- Agammaglobulinemia, Agranulocytosis, Blood Protein Disorders, +22 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
- Locations
-
- Octapharma Research Site St. Petersburg, Florida, United States
- Octapharma Research Site Columbus, Georgia, United States
- Octapharma Research Site Macon, Georgia, United States
- Octapharma Research Site New Orleans, Louisiana, United States
NCT00161993
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Tampere University Hospital Tampere, Finland
- Turku University Central Hospital Turku, Finland
- SU/Sahlgrenska Gothenburg, Sweden
- University Hospital Lund Lund, Sweden
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
NCT01581593
- Conditions
- Agammaglobulinemia, Antibody Deficiency, Blood Protein Disorders, +11 more
- Locations
-
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
- Family Allergy & Asthma Center, PC Atlanta, Georgia, United States
- Rush University Chicago, Illinois, United States
NCT02508584
- Conditions
- Agammaglobulinemia, Arthritis, Arthritis, Infectious, +15 more
- Locations
-
- Brigham and Women's Hosptial Boston, Massachusetts, United States
NCT03401268
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +6 more
- Locations
-
- Princess Margaret Hospital Toronto, Ontario, Canada
NCT01002755
- Conditions
- Agammaglobulinemia, Blood Platelet Disorders, Blood Protein Disorders, +33 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT00115778
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +7 more
- Locations
-
- New York Presbyterian Hospital Lung Transplant Program New York, United States
NCT02043379
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Cardiovascular Abnormalities, +13 more
- Locations
-
- Children's of Alabama Birmingham, Alabama, United States
NCT00278954
- Conditions
- Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +26 more
- Locations
-
- Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
- Family Allergy and Asthma Center PC Atlanta, Georgia, United States
- Rush University Medical Centre, University Consultants in Allergy & Immunology Chicago, Illinois, United States
- Childrens Hospital at Buffalo, Allergy Division Buffalo, New York, United States
NCT00137748
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +6 more
- Locations
-
- Cleveland Clinic Foundation Cleveland, Ohio, United States
NCT00138697
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +6 more
- Locations
-
- Medical Centre Alkmaar Alkmaar, Netherlands
- Academic Medical Centre Amsterdam, Netherlands
- Academic Hospital Groningen Groningen, Netherlands
- LUMC Leiden, Netherlands